<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.psychiatrienet.nl/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lenneke</id>
	<title>Psychiatrienet - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.psychiatrienet.nl/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lenneke"/>
	<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/wiki/Special:Contributions/Lenneke"/>
	<updated>2026-05-16T00:57:59Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.31.6</generator>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6403</id>
		<title>Stop-venlafaxine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6403"/>
		<updated>2011-07-19T09:29:37Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day {{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|9396960|Fava M et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec;154(12):1760-2}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of venlafaxine to 37.5 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of venlafaxine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-trazodone&amp;diff=6402</id>
		<title>Stop-trazodone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-trazodone&amp;diff=6402"/>
		<updated>2011-07-19T09:25:00Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = trazodone&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 400 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of trazodone to 300 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of trazodone to 200 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of trazodone to 100 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of trazodone to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of trazodone.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-tranylcypromine&amp;diff=6401</id>
		<title>Stop-tranylcypromine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-tranylcypromine&amp;diff=6401"/>
		<updated>2011-07-19T09:24:03Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = tranylcypromine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 60 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of tranylcypromine to 50 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of tranylcypromine to 40 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of tranylcypromine to 30 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of tranylcypromine to 20 mg/day. &lt;br /&gt;
:* '''Day 29:''' reduce dosage of tranylcypromine to 10 mg/day. &lt;br /&gt;
:* '''Day 36:''' stop administration of tranylcypromine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6400</id>
		<title>Stop-sertraline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6400"/>
		<updated>2011-07-19T08:39:01Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = sertraline&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 150 mg/day &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.](dutch)&amp;lt;/ref&amp;gt;{{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of sertraline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6399</id>
		<title>Stop-paroxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6399"/>
		<updated>2011-07-19T08:38:05Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 30 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.(Dutch)&amp;lt;/ref&amp;gt;{{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|16863271|Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs. 2006;20(8):665-72}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of paroxetine to 20 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of paroxetine to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of paroxetine to 5 mg/day (preferably in 2 doses). &lt;br /&gt;
:* '''Day 22:''' reduce dosage of paroxetine to 2,5 mg/day (preferably in 2 doses). &lt;br /&gt;
:* '''Day 29:''' stop administration of paroxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-nortriptyline&amp;diff=6398</id>
		<title>Stop-nortriptyline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-nortriptyline&amp;diff=6398"/>
		<updated>2011-07-19T08:33:51Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = nortriptyline&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of nortriptyline to 100 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of nortriptyline to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of nortriptyline to 25 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of nortriptyline to 10 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of nortriptyline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-nortriptyline&amp;diff=6397</id>
		<title>Stop-nortriptyline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-nortriptyline&amp;diff=6397"/>
		<updated>2011-07-19T08:33:37Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = nortriptyline&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day {refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of nortriptyline to 100 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of nortriptyline to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of nortriptyline to 25 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of nortriptyline to 10 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of nortriptyline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-moclobemide&amp;diff=6396</id>
		<title>Stop-moclobemide</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-moclobemide&amp;diff=6396"/>
		<updated>2011-07-19T08:32:38Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = moclobemide&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 300 mg/day {{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|12236637|Curtin F et al. Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms. J Psychopharmacol. 2002 Sep;16(3):271-2}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of  moclobemide to 150 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of moclobemide to 75 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop the administration of moclobemide.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-moclobemide&amp;diff=6395</id>
		<title>Stop-moclobemide</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-moclobemide&amp;diff=6395"/>
		<updated>2011-07-19T08:32:27Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = moclobemide&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 300 mg/day {{ferBazire}}&amp;lt;ref&amp;gt;{{Pubmed|12236637|Curtin F et al. Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms. J Psychopharmacol. 2002 Sep;16(3):271-2}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of  moclobemide to 150 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of moclobemide to 75 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop the administration of moclobemide.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-mirtazapine&amp;diff=6394</id>
		<title>Stop-mirtazapine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-mirtazapine&amp;diff=6394"/>
		<updated>2011-07-19T08:22:23Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = mirtazepine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 45 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of  mirtazepine to 30 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of mirtazepine to 15 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop the administration of mirtazepine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-maprotiline&amp;diff=6393</id>
		<title>Stop-maprotiline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-maprotiline&amp;diff=6393"/>
		<updated>2011-07-19T08:19:03Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = maprotiline&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 75 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of maprotiline to 50 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of maprotiline to 25 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop the administration of maprotiline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-imipramine&amp;diff=6392</id>
		<title>Stop-imipramine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-imipramine&amp;diff=6392"/>
		<updated>2011-07-19T08:18:12Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = imipramine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day {{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of imipramine to 100 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of imipramine to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of imipramine to 50 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of imipramine to 25 mg/day.&lt;br /&gt;
:* '''Day 29:''' stop the administration of imipramine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluvoxamine&amp;diff=6390</id>
		<title>Stop-fluvoxamine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluvoxamine&amp;diff=6390"/>
		<updated>2011-07-19T08:10:46Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = fluvoxamine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* ≥ 150 mg/day &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.](dutch)&amp;lt;/ref&amp;gt;{{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of fluvoxamine to 100 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of fluvoxamine to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of fluvoxamine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-escitalopram&amp;diff=6389</id>
		<title>Stop-escitalopram</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-escitalopram&amp;diff=6389"/>
		<updated>2011-07-19T08:08:52Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = escitalopram&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 20 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.(Dutch)&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11110008|Markowitz JS et al. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram. Int Clin Psychopharmacol. 2000 Nov;15(6):329-33}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of citalopram to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' stop administration of citalopram.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-escitalopram&amp;diff=6388</id>
		<title>Stop-escitalopram</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-escitalopram&amp;diff=6388"/>
		<updated>2011-07-19T08:08:10Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = escitalopram&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 20 mg/day &amp;lt;ref&amp;gt;{{Pubmed|11110008|Markowitz JS et al. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram. Int Clin Psychopharmacol. 2000 Nov;15(6):329-33}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of citalopram to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' stop administration of citalopram.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6387</id>
		<title>Stop-duloxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6387"/>
		<updated>2011-07-19T08:03:36Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| stop = &lt;br /&gt;
* Plain stop {{refBazire}}&amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.(Dutch)&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of duloxetine to 60 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of duloxetine to 30 mg/day. &lt;br /&gt;
:* '''Day 29 or later:''' stop administration of duloxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-doxepin&amp;diff=6386</id>
		<title>Stop-doxepin</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-doxepin&amp;diff=6386"/>
		<updated>2011-07-19T07:56:18Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = doxepin&lt;br /&gt;
| stop = {{StopAlgemeen}}{{refBazire}}&lt;br /&gt;
* 150 mg/day:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of doxepin to 100 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of doxepin to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of doxepin to 50 mg/day. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of doxepin to 25 mg/day.&lt;br /&gt;
:* '''Day 30:''' stop the administration of doxepin.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-dosulepine&amp;diff=6385</id>
		<title>Stop-dosulepine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-dosulepine&amp;diff=6385"/>
		<updated>2011-07-19T07:55:12Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = Dosulepin&lt;br /&gt;
| stop = {{StopAlgemeen}}{{refBazire}}&lt;br /&gt;
{{ReduceMedication|dosulepin|150|100|75|50|25}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-clomipramine&amp;diff=6384</id>
		<title>Stop-clomipramine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-clomipramine&amp;diff=6384"/>
		<updated>2011-07-19T07:51:13Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = clomipramine &lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|8889907|Coupland NJ et al. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996 Oct;16(5):356-62}}&amp;lt;/ref&amp;gt;{{refBazire}}&lt;br /&gt;
{{ReduceMedication|clomipramine|150|75|50|25|10}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-clomipramine&amp;diff=6383</id>
		<title>Stop-clomipramine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-clomipramine&amp;diff=6383"/>
		<updated>2011-07-19T07:50:00Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = clomipramine &lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|8889907|Coupland NJ et al. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996 Oct;16(5):356-62}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
{{ReduceMedication|clomipramine|150|75|50|25|10}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-citalopram&amp;diff=6382</id>
		<title>Stop-citalopram</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-citalopram&amp;diff=6382"/>
		<updated>2011-07-19T07:41:45Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = citalopram&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|11110008|Markowitz JS et al. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram. Int Clin Psychopharmacol. 2000 Nov;15(6):329-33}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
{{ReduceMedication|citalopram|40|30|20|10}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-bupropion&amp;diff=6381</id>
		<title>Stop-bupropion</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-bupropion&amp;diff=6381"/>
		<updated>2011-07-19T07:29:01Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Bupropion&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 300 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.(Dutch)&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:* '''Day 1:''' reduce dosage of bupropion to 150 mg/day.&lt;br /&gt;
:* '''Day 15:''' stop administration of bupropion.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-bupropion&amp;diff=6380</id>
		<title>Stop-bupropion</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-bupropion&amp;diff=6380"/>
		<updated>2011-07-19T07:25:19Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Bupropion&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 300 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.(Dutch)&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:* '''Day 1:''' reduce dosage of bupropion to a maximum of 150 mg/day in two weeks.&lt;br /&gt;
:* '''Day 15:''' stop administration of bupropion.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-amitriptyline&amp;diff=6379</id>
		<title>Stop-amitriptyline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-amitriptyline&amp;diff=6379"/>
		<updated>2011-07-19T07:15:26Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Amitriptyline&lt;br /&gt;
| stop = {{StopAlgemeen}} &lt;br /&gt;
* '''100 mg/day {{refBazire}}:'''&lt;br /&gt;
:* '''Day 1:''' reduce dosage of amitriptyline to 75 mg/day.&lt;br /&gt;
:* '''Day 8:''' reduce dosage of amitriptyline to 50 mg/day.&lt;br /&gt;
:* '''Day 15:''' reduce dosage of amitriptyline to 25 mg/day.&lt;br /&gt;
:* '''Day 22:''' reduce dosage of amitriptyline to 10 mg/day.&lt;br /&gt;
:* '''Day 29:''' stop administration of amitriptyline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-agomelatine&amp;diff=6378</id>
		<title>Stop-agomelatine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-agomelatine&amp;diff=6378"/>
		<updated>2011-07-19T06:55:29Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = agomelatine &lt;br /&gt;
| stop = {{StopAgomelatine}}&amp;lt;ref name=&amp;quot;montgomery&amp;quot;&amp;gt;{{RefMontgomery}}&amp;lt;/ref&amp;gt;{{refBazire}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6377</id>
		<title>Stop-sertraline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6377"/>
		<updated>2011-07-19T06:53:02Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = sertraline&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 150 mg/day &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.](dutch)&amp;lt;/ref&amp;gt;{{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of sertraline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6376</id>
		<title>Stop-paroxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6376"/>
		<updated>2011-07-19T06:51:40Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 30 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.(Dutch)&amp;lt;/ref&amp;gt;{{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|16863271|Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs. 2006;20(8):665-72}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of paroxetine to 20 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of paroxetine to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of paroxetine to 5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of paroxetine to 2,5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 29:''' stop administration of paroxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6375</id>
		<title>Stop-fluoxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6375"/>
		<updated>2011-07-19T06:49:05Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| stop = {{StopFluoxetine}} {{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|9617977|Zajecka J et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychopharmacol. 1998 Jun;18(3):193-7}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* 40 mg/day:&lt;br /&gt;
:*'''Day 1:''' reduce the dosage of fluoxetine to 20 mg/day.&lt;br /&gt;
:* '''Day 15:''' stop the administration of fluoxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6374</id>
		<title>Stop-venlafaxine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6374"/>
		<updated>2011-07-19T06:46:53Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day &amp;lt;ref&amp;gt;{{Pubmed|9396960|Fava M et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec;154(12):1760-2}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of venlafaxine to 37.5 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of venlafaxine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6373</id>
		<title>Stop-venlafaxine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-venlafaxine&amp;diff=6373"/>
		<updated>2011-07-18T13:38:26Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* 150 mg/day &amp;lt;ref&amp;gt;{{Pubmed|9396960|Fava M et al. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry. 1997 Dec;154(12):1760-2}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of venlafaxine to 75 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of venlafaxine to 37.5 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of venlafaxine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6372</id>
		<title>Stop-sertraline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6372"/>
		<updated>2011-07-18T12:36:47Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = sertraline&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 150 mg/day &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.](dutch)&amp;lt;/ref&amp;gt;{{refBazire}}:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of sertraline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6371</id>
		<title>Stop-sertraline</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-sertraline&amp;diff=6371"/>
		<updated>2011-07-18T12:35:59Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = sertraline&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 150 mg/day &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.](dutch)&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. &lt;br /&gt;
:* '''Day 29:''' stop administration of sertraline.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6370</id>
		<title>Stop-fluoxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6370"/>
		<updated>2011-07-18T12:35:10Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| stop = {{StopFluoxetine}} {{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|9617977|Zajecka J et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychopharmacol. 1998 Jun;18(3):193-7}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* 40 mg/day:&lt;br /&gt;
:*'''Day 1:''' reduce the dosage of fluoxetine to 20 mg/day.&lt;br /&gt;
:* '''Day 15:''' stop the administration of fluoxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6369</id>
		<title>Stop-paroxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6369"/>
		<updated>2011-07-18T12:34:30Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| stop = {{StopAlgemeen}}&amp;lt;ref&amp;gt;{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
* ≥ 30 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.(Dutch)&amp;lt;/ref&amp;gt;{{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|16863271|Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs. 2006;20(8):665-72}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of paroxetine to 20 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of paroxetine to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of paroxetine to 5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of paroxetine to 2,5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 29:''' stop administration of paroxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6367</id>
		<title>User talk:Musys/oud</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6367"/>
		<updated>2011-07-18T11:49:46Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: /* Pubmed */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div style=&amp;quot;background:#FFE0E0; border-style:solid; border-color:maroon; margin:10px; padding:10px;&amp;quot;&amp;gt;&lt;br /&gt;
* Tik hieronder een berichtje om iets te vragen. &lt;br /&gt;
* Nieuw overleg graag onderaan toevoegen (&amp;lt;ctrl-end&amp;gt; voor einde pagina)&lt;br /&gt;
* onderteken overleg met vier tildes &amp;lt;nowiki&amp;gt;~~~~&amp;lt;/nowiki&amp;gt; dan wordt duidelijk wie wat wanneer geschreven heeft.&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Tabel veranderen ==&lt;br /&gt;
Beste Arent,&lt;br /&gt;
&lt;br /&gt;
Ik zou graag de tabel op de hoofdpagina willen veranderen. &lt;br /&gt;
Als die verandert is, kan ik het verder gaan invullen met de informatie die ik verzameld heb.&lt;br /&gt;
Heb me ook al een beetje verdiept in het 'schrijven' in wiki.&lt;br /&gt;
Voor de tabel zou ik het volgende willen:&lt;br /&gt;
&lt;br /&gt;
* TCA&lt;br /&gt;
** amitriptyline&lt;br /&gt;
** clomipramine&lt;br /&gt;
** dosulepine&lt;br /&gt;
** doxepine&lt;br /&gt;
** imipramine&lt;br /&gt;
** maprotiline&lt;br /&gt;
** nortriptyline&lt;br /&gt;
* SSRI&lt;br /&gt;
** citalopram/escitalopram&lt;br /&gt;
** fluoxetine&lt;br /&gt;
** fluvoxamine&lt;br /&gt;
** paroxetine&lt;br /&gt;
** sertraline&lt;br /&gt;
* SNRI&lt;br /&gt;
** duloxetine&lt;br /&gt;
** venlafaxine&lt;br /&gt;
* MAOi&lt;br /&gt;
** moclobemide&lt;br /&gt;
** tranylcypromine&lt;br /&gt;
* bupropion&lt;br /&gt;
* hypericum&lt;br /&gt;
* mianserine&lt;br /&gt;
* mirtazapine&lt;br /&gt;
* oxitriptan&lt;br /&gt;
* trazodone&lt;br /&gt;
&lt;br /&gt;
Als het dan mogelijk is dat dit rijtje op de x-as en op de y-as komt te staan?&lt;br /&gt;
'''''Alvast bedankt!'''''&lt;br /&gt;
&lt;br /&gt;
Mvg,&lt;br /&gt;
&lt;br /&gt;
[[User:Alexandra|Alexandra]] 13:53, 21 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: Even vlug geteld lijken dat er 22. &lt;br /&gt;
: Zou net moeten kunnen.&lt;br /&gt;
: Als het er echt veel meer worden past de tabel niet meer op een (groot) scherm en moeten we iets anders bedenken als introductie overzicht.&lt;br /&gt;
: De wiki op psychiatrienet.nl is vanochtend in bedrijf gekomen. Er moeten nog wat extensies geïnstalleerd worden en dan kunnen we verder op http://wiki.psychiatrienet.nl &lt;br /&gt;
: Heb je al idee over de te bieden informatie in de sjabloontjes (zoals [[:Med:Moclobemide]]? &lt;br /&gt;
:&lt;br /&gt;
: Ik zie net dat het overschakelen op engels als standaardtaal voor de wiki wat onverwachte gevolgen heeft (zoals je zelf geloof ik al gemerkt hebt met Talk/Overleg). 'For the time being' kun je deze wiki als klad gebruiken. Probeer gerust alles uit. Als er rook uit je computer komt: 112 ;-) - [[User:Musys|musys]] 14:01, 22 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Dank je wel.&lt;br /&gt;
Waarschijnlijk kunnen er nog twee geneesmiddelen tussenuit, maar dat moet ik nog met Walter bespreken.&lt;br /&gt;
Dus de tabel zal niet groter worden.&lt;br /&gt;
En kunnen we voor de informatie in de sjabloontjes niet gewoon verwijzen naar de website van het farmacotherapeutisch&lt;br /&gt;
kompas op http://www.fk.cvz.nl ?&lt;br /&gt;
Groet, [[User:Alexandra|Alexandra]] 12:51, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: met &amp;lt;tt&amp;gt;ftk = NAAM&amp;lt;/tt&amp;gt; kun je inmiddels naar het kompas verwijzen. Wil je eigenlijk op een internationaal georiënteerde site verwijzen naar Nederlandstalige informatie? - [[User:Musys|musys]] 19:21, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Hoe kan ik op de hoofdpagina de termen LA en MA in een kleiner lettertype krijgen?&lt;br /&gt;
&lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
: bedoel je zo als nu op [[SwitchAntipsychotics]]?&lt;br /&gt;
:hier is&lt;br /&gt;
&amp;lt;pre&amp;gt; tx21 = NaamVanMiddel &amp;lt;small&amp;gt;LA&amp;lt;/small&amp;gt; &amp;lt;/pre&amp;gt;&lt;br /&gt;
: gebruikt - [[User:Musys|Arent]] 13:47, 28 July 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
hoi, &lt;br /&gt;
Ik heb net {{red}} geprobeerd, maar bij mij blijven de letters gewoon zwart, ook in het het &lt;br /&gt;
voorbeeld dat jij net gemaakt hebt.&lt;br /&gt;
&lt;br /&gt;
groetjes Verena&lt;br /&gt;
: Even de {{red|cache}} leegmaken (shift-refresh/ctrl-F5) zou moeten helpen. - [[User:Musys|Arent]] 13:49, 6 August 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
Dat heeft geholpen! bedankt! Ik zal het nu gaan invullen zoals je voorstelde &lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
==telefoonnummer==&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik ben vandaag bij Walter begonnen. Als proef wil ik je telefoonnummer vragen.&lt;br /&gt;
Kan je dat hier neerzetten of me mailen.&lt;br /&gt;
&lt;br /&gt;
Groetjes,&lt;br /&gt;
&lt;br /&gt;
Ashni&lt;br /&gt;
&lt;br /&gt;
: Dag Ashni, welkom op de site. Je kunt me bereiken op 040-2920959  - [[User:Musys|Arent]] 14:28, 19 April 2010 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Pubmed ==&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik kom er niet uit hoe ik een bron met link naar pubmed toe moet voegen. Het lukt me alleen als ik een template aanmaak. Kun je me vertellen hoe ik een bron kan toevoegen?&lt;br /&gt;
&lt;br /&gt;
Bedankt!&lt;br /&gt;
&lt;br /&gt;
Groetjes, Lenneke&lt;br /&gt;
&lt;br /&gt;
[[User:Lenneke|Lenneke]] 10:34, 18 July 2011 (CEST)&lt;br /&gt;
&lt;br /&gt;
:Ik heb op [[Stop-paroxetine]] het gebruik van [[template:RefHimei]] er even tussenuit gehaald:&lt;br /&gt;
::http://wiki.psychiatrienet.nl/index.php?title=Stop-paroxetine&amp;amp;action=historysubmit&amp;amp;diff=6362&amp;amp;oldid=6356&lt;br /&gt;
:Zo wat duidelijker? - [[User:Musys|Arent]] 10:48, 18 July 2011 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bedankt, het is duidelijk!&lt;br /&gt;
Ik heb iets met template;2 geprobeerd, omdat ik dacht dat ik die moest gebruiken voor een pubmed bron. Ik heb het wel weer weggehaald. Wil jij kijken of dat goed is gegaan? Bedankt!&lt;br /&gt;
&lt;br /&gt;
Groetjes, Lenneke&lt;br /&gt;
&lt;br /&gt;
[[User:Lenneke|Lenneke]] 13:49, 18 July 2011 (CEST)&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6366</id>
		<title>Stop-fluoxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6366"/>
		<updated>2011-07-18T11:46:41Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| stop = {{StopFluoxetine}} {{refBazire}}&amp;lt;ref&amp;gt;{{Pubmed|9617977|Zajecka J et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychopharmacol. 1998 Jun;18(3):193-7}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 40 mg/day:&lt;br /&gt;
:*'''Day 1:''' reduce the dosage of fluoxetine to 20 mg/day.&lt;br /&gt;
:* '''Day 15:''' stop the administration of fluoxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6361</id>
		<title>User talk:Musys/oud</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6361"/>
		<updated>2011-07-18T08:34:17Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: /* Pubmed */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div style=&amp;quot;background:#FFE0E0; border-style:solid; border-color:maroon; margin:10px; padding:10px;&amp;quot;&amp;gt;&lt;br /&gt;
* Tik hieronder een berichtje om iets te vragen. &lt;br /&gt;
* Nieuw overleg graag onderaan toevoegen (&amp;lt;ctrl-end&amp;gt; voor einde pagina)&lt;br /&gt;
* onderteken overleg met vier tildes &amp;lt;nowiki&amp;gt;~~~~&amp;lt;/nowiki&amp;gt; dan wordt duidelijk wie wat wanneer geschreven heeft.&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Tabel veranderen ==&lt;br /&gt;
Beste Arent,&lt;br /&gt;
&lt;br /&gt;
Ik zou graag de tabel op de hoofdpagina willen veranderen. &lt;br /&gt;
Als die verandert is, kan ik het verder gaan invullen met de informatie die ik verzameld heb.&lt;br /&gt;
Heb me ook al een beetje verdiept in het 'schrijven' in wiki.&lt;br /&gt;
Voor de tabel zou ik het volgende willen:&lt;br /&gt;
&lt;br /&gt;
* TCA&lt;br /&gt;
** amitriptyline&lt;br /&gt;
** clomipramine&lt;br /&gt;
** dosulepine&lt;br /&gt;
** doxepine&lt;br /&gt;
** imipramine&lt;br /&gt;
** maprotiline&lt;br /&gt;
** nortriptyline&lt;br /&gt;
* SSRI&lt;br /&gt;
** citalopram/escitalopram&lt;br /&gt;
** fluoxetine&lt;br /&gt;
** fluvoxamine&lt;br /&gt;
** paroxetine&lt;br /&gt;
** sertraline&lt;br /&gt;
* SNRI&lt;br /&gt;
** duloxetine&lt;br /&gt;
** venlafaxine&lt;br /&gt;
* MAOi&lt;br /&gt;
** moclobemide&lt;br /&gt;
** tranylcypromine&lt;br /&gt;
* bupropion&lt;br /&gt;
* hypericum&lt;br /&gt;
* mianserine&lt;br /&gt;
* mirtazapine&lt;br /&gt;
* oxitriptan&lt;br /&gt;
* trazodone&lt;br /&gt;
&lt;br /&gt;
Als het dan mogelijk is dat dit rijtje op de x-as en op de y-as komt te staan?&lt;br /&gt;
'''''Alvast bedankt!'''''&lt;br /&gt;
&lt;br /&gt;
Mvg,&lt;br /&gt;
&lt;br /&gt;
[[User:Alexandra|Alexandra]] 13:53, 21 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: Even vlug geteld lijken dat er 22. &lt;br /&gt;
: Zou net moeten kunnen.&lt;br /&gt;
: Als het er echt veel meer worden past de tabel niet meer op een (groot) scherm en moeten we iets anders bedenken als introductie overzicht.&lt;br /&gt;
: De wiki op psychiatrienet.nl is vanochtend in bedrijf gekomen. Er moeten nog wat extensies geïnstalleerd worden en dan kunnen we verder op http://wiki.psychiatrienet.nl &lt;br /&gt;
: Heb je al idee over de te bieden informatie in de sjabloontjes (zoals [[:Med:Moclobemide]]? &lt;br /&gt;
:&lt;br /&gt;
: Ik zie net dat het overschakelen op engels als standaardtaal voor de wiki wat onverwachte gevolgen heeft (zoals je zelf geloof ik al gemerkt hebt met Talk/Overleg). 'For the time being' kun je deze wiki als klad gebruiken. Probeer gerust alles uit. Als er rook uit je computer komt: 112 ;-) - [[User:Musys|musys]] 14:01, 22 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Dank je wel.&lt;br /&gt;
Waarschijnlijk kunnen er nog twee geneesmiddelen tussenuit, maar dat moet ik nog met Walter bespreken.&lt;br /&gt;
Dus de tabel zal niet groter worden.&lt;br /&gt;
En kunnen we voor de informatie in de sjabloontjes niet gewoon verwijzen naar de website van het farmacotherapeutisch&lt;br /&gt;
kompas op http://www.fk.cvz.nl ?&lt;br /&gt;
Groet, [[User:Alexandra|Alexandra]] 12:51, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: met &amp;lt;tt&amp;gt;ftk = NAAM&amp;lt;/tt&amp;gt; kun je inmiddels naar het kompas verwijzen. Wil je eigenlijk op een internationaal georiënteerde site verwijzen naar Nederlandstalige informatie? - [[User:Musys|musys]] 19:21, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Hoe kan ik op de hoofdpagina de termen LA en MA in een kleiner lettertype krijgen?&lt;br /&gt;
&lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
: bedoel je zo als nu op [[SwitchAntipsychotics]]?&lt;br /&gt;
:hier is&lt;br /&gt;
&amp;lt;pre&amp;gt; tx21 = NaamVanMiddel &amp;lt;small&amp;gt;LA&amp;lt;/small&amp;gt; &amp;lt;/pre&amp;gt;&lt;br /&gt;
: gebruikt - [[User:Musys|Arent]] 13:47, 28 July 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
hoi, &lt;br /&gt;
Ik heb net {{red}} geprobeerd, maar bij mij blijven de letters gewoon zwart, ook in het het &lt;br /&gt;
voorbeeld dat jij net gemaakt hebt.&lt;br /&gt;
&lt;br /&gt;
groetjes Verena&lt;br /&gt;
: Even de {{red|cache}} leegmaken (shift-refresh/ctrl-F5) zou moeten helpen. - [[User:Musys|Arent]] 13:49, 6 August 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
Dat heeft geholpen! bedankt! Ik zal het nu gaan invullen zoals je voorstelde &lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
==telefoonnummer==&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik ben vandaag bij Walter begonnen. Als proef wil ik je telefoonnummer vragen.&lt;br /&gt;
Kan je dat hier neerzetten of me mailen.&lt;br /&gt;
&lt;br /&gt;
Groetjes,&lt;br /&gt;
&lt;br /&gt;
Ashni&lt;br /&gt;
&lt;br /&gt;
: Dag Ashni, welkom op de site. Je kunt me bereiken op 040-2920959  - [[User:Musys|Arent]] 14:28, 19 April 2010 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Pubmed ==&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik kom er niet uit hoe ik een bron met link naar pubmed toe moet voegen. Het lukt me alleen als ik een template aanmaak. Kun je me vertellen hoe ik een bron kan toevoegen?&lt;br /&gt;
&lt;br /&gt;
Bedankt!&lt;br /&gt;
&lt;br /&gt;
Groetjes, Lenneke&lt;br /&gt;
&lt;br /&gt;
[[User:Lenneke|Lenneke]] 10:34, 18 July 2011 (CEST)&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6360</id>
		<title>User talk:Musys/oud</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=User_talk:Musys/oud&amp;diff=6360"/>
		<updated>2011-07-18T08:32:57Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: /* pubmed */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div style=&amp;quot;background:#FFE0E0; border-style:solid; border-color:maroon; margin:10px; padding:10px;&amp;quot;&amp;gt;&lt;br /&gt;
* Tik hieronder een berichtje om iets te vragen. &lt;br /&gt;
* Nieuw overleg graag onderaan toevoegen (&amp;lt;ctrl-end&amp;gt; voor einde pagina)&lt;br /&gt;
* onderteken overleg met vier tildes &amp;lt;nowiki&amp;gt;~~~~&amp;lt;/nowiki&amp;gt; dan wordt duidelijk wie wat wanneer geschreven heeft.&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Tabel veranderen ==&lt;br /&gt;
Beste Arent,&lt;br /&gt;
&lt;br /&gt;
Ik zou graag de tabel op de hoofdpagina willen veranderen. &lt;br /&gt;
Als die verandert is, kan ik het verder gaan invullen met de informatie die ik verzameld heb.&lt;br /&gt;
Heb me ook al een beetje verdiept in het 'schrijven' in wiki.&lt;br /&gt;
Voor de tabel zou ik het volgende willen:&lt;br /&gt;
&lt;br /&gt;
* TCA&lt;br /&gt;
** amitriptyline&lt;br /&gt;
** clomipramine&lt;br /&gt;
** dosulepine&lt;br /&gt;
** doxepine&lt;br /&gt;
** imipramine&lt;br /&gt;
** maprotiline&lt;br /&gt;
** nortriptyline&lt;br /&gt;
* SSRI&lt;br /&gt;
** citalopram/escitalopram&lt;br /&gt;
** fluoxetine&lt;br /&gt;
** fluvoxamine&lt;br /&gt;
** paroxetine&lt;br /&gt;
** sertraline&lt;br /&gt;
* SNRI&lt;br /&gt;
** duloxetine&lt;br /&gt;
** venlafaxine&lt;br /&gt;
* MAOi&lt;br /&gt;
** moclobemide&lt;br /&gt;
** tranylcypromine&lt;br /&gt;
* bupropion&lt;br /&gt;
* hypericum&lt;br /&gt;
* mianserine&lt;br /&gt;
* mirtazapine&lt;br /&gt;
* oxitriptan&lt;br /&gt;
* trazodone&lt;br /&gt;
&lt;br /&gt;
Als het dan mogelijk is dat dit rijtje op de x-as en op de y-as komt te staan?&lt;br /&gt;
'''''Alvast bedankt!'''''&lt;br /&gt;
&lt;br /&gt;
Mvg,&lt;br /&gt;
&lt;br /&gt;
[[User:Alexandra|Alexandra]] 13:53, 21 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: Even vlug geteld lijken dat er 22. &lt;br /&gt;
: Zou net moeten kunnen.&lt;br /&gt;
: Als het er echt veel meer worden past de tabel niet meer op een (groot) scherm en moeten we iets anders bedenken als introductie overzicht.&lt;br /&gt;
: De wiki op psychiatrienet.nl is vanochtend in bedrijf gekomen. Er moeten nog wat extensies geïnstalleerd worden en dan kunnen we verder op http://wiki.psychiatrienet.nl &lt;br /&gt;
: Heb je al idee over de te bieden informatie in de sjabloontjes (zoals [[:Med:Moclobemide]]? &lt;br /&gt;
:&lt;br /&gt;
: Ik zie net dat het overschakelen op engels als standaardtaal voor de wiki wat onverwachte gevolgen heeft (zoals je zelf geloof ik al gemerkt hebt met Talk/Overleg). 'For the time being' kun je deze wiki als klad gebruiken. Probeer gerust alles uit. Als er rook uit je computer komt: 112 ;-) - [[User:Musys|musys]] 14:01, 22 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Dank je wel.&lt;br /&gt;
Waarschijnlijk kunnen er nog twee geneesmiddelen tussenuit, maar dat moet ik nog met Walter bespreken.&lt;br /&gt;
Dus de tabel zal niet groter worden.&lt;br /&gt;
En kunnen we voor de informatie in de sjabloontjes niet gewoon verwijzen naar de website van het farmacotherapeutisch&lt;br /&gt;
kompas op http://www.fk.cvz.nl ?&lt;br /&gt;
Groet, [[User:Alexandra|Alexandra]] 12:51, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
: met &amp;lt;tt&amp;gt;ftk = NAAM&amp;lt;/tt&amp;gt; kun je inmiddels naar het kompas verwijzen. Wil je eigenlijk op een internationaal georiënteerde site verwijzen naar Nederlandstalige informatie? - [[User:Musys|musys]] 19:21, 23 April 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Hoe kan ik op de hoofdpagina de termen LA en MA in een kleiner lettertype krijgen?&lt;br /&gt;
&lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
: bedoel je zo als nu op [[SwitchAntipsychotics]]?&lt;br /&gt;
:hier is&lt;br /&gt;
&amp;lt;pre&amp;gt; tx21 = NaamVanMiddel &amp;lt;small&amp;gt;LA&amp;lt;/small&amp;gt; &amp;lt;/pre&amp;gt;&lt;br /&gt;
: gebruikt - [[User:Musys|Arent]] 13:47, 28 July 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
hoi, &lt;br /&gt;
Ik heb net {{red}} geprobeerd, maar bij mij blijven de letters gewoon zwart, ook in het het &lt;br /&gt;
voorbeeld dat jij net gemaakt hebt.&lt;br /&gt;
&lt;br /&gt;
groetjes Verena&lt;br /&gt;
: Even de {{red|cache}} leegmaken (shift-refresh/ctrl-F5) zou moeten helpen. - [[User:Musys|Arent]] 13:49, 6 August 2009 (CEST)&lt;br /&gt;
&lt;br /&gt;
Dat heeft geholpen! bedankt! Ik zal het nu gaan invullen zoals je voorstelde &lt;br /&gt;
groeten Verena&lt;br /&gt;
&lt;br /&gt;
==telefoonnummer==&lt;br /&gt;
&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik ben vandaag bij Walter begonnen. Als proef wil ik je telefoonnummer vragen.&lt;br /&gt;
Kan je dat hier neerzetten of me mailen.&lt;br /&gt;
&lt;br /&gt;
Groetjes,&lt;br /&gt;
&lt;br /&gt;
Ashni&lt;br /&gt;
&lt;br /&gt;
: Dag Ashni, welkom op de site. Je kunt me bereiken op 040-2920959  - [[User:Musys|Arent]] 14:28, 19 April 2010 (CEST)&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Pubmed ==&lt;br /&gt;
Hoi Arent,&lt;br /&gt;
&lt;br /&gt;
Ik kom er niet uit hoe ik een bron met link naar pubmed toe moet voegen. Het lukt me alleen als ik een template aanmaak. Kun je me vertellen hoe ik een bron kan toevoegen?&lt;br /&gt;
&lt;br /&gt;
Bedankt!&lt;br /&gt;
&lt;br /&gt;
Groetjes, Lenneke&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6359</id>
		<title>Stop-fluoxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-fluoxetine&amp;diff=6359"/>
		<updated>2011-07-18T07:10:00Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| stop = {{StopFluoxetine}} {{refBazire}}&lt;br /&gt;
* 40 mg/day:&lt;br /&gt;
:*'''Day 1:''' reduce the dosage of fluoxetine to 20 mg/day.&lt;br /&gt;
:* '''Day 15:''' stop the administration of fluoxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6356</id>
		<title>Stop-paroxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-paroxetine&amp;diff=6356"/>
		<updated>2011-07-14T13:33:34Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| stop = {{StopAlgemeen}}&lt;br /&gt;
* ≥ 30 mg/day &amp;lt;ref&amp;gt;Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.(Dutch)&amp;lt;/ref&amp;gt; {{refBazire}} &amp;lt;ref name=&amp;quot;himei&amp;quot;&amp;gt;{{RefHimei}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of paroxetine to 20 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of paroxetine to 10 mg/day. &lt;br /&gt;
:* '''Day 15:''' reduce dosage of paroxetine to 5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 22:''' reduce dosage of paroxetine to 2,5 mg/day in 2 doses. &lt;br /&gt;
:* '''Day 29:''' stop administration of paroxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefHimei&amp;diff=6355</id>
		<title>Template:RefHimei</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefHimei&amp;diff=6355"/>
		<updated>2011-07-14T13:31:51Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Pubmed|16863271|Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs. 2006;20(8):665-72}}&lt;br /&gt;
&amp;lt;noinclude&amp;gt;[[Category:References]]&amp;lt;/noinclude&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefHimei&amp;diff=6354</id>
		<title>Template:RefHimei</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefHimei&amp;diff=6354"/>
		<updated>2011-07-14T13:29:41Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: Created page with 'Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Himei A, Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs. 2006;20(8):665-72&lt;br /&gt;
&amp;lt;noinclude&amp;gt;[[Category:References]]&amp;lt;/noinclude&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-agomelatine&amp;diff=6353</id>
		<title>Stop-agomelatine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-agomelatine&amp;diff=6353"/>
		<updated>2011-07-14T12:04:46Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = agomelatine &lt;br /&gt;
| stop = {{StopAgomelatine}} &amp;lt;ref name=&amp;quot;montgomery&amp;quot;&amp;gt;{{RefMontgomery}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefMontgomery&amp;diff=6352</id>
		<title>Template:RefMontgomery</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefMontgomery&amp;diff=6352"/>
		<updated>2011-07-14T12:01:14Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: Created page with '{{Pubmed|15289700|Montgomery SA et al. Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Pubmed|15289700|Montgomery SA et al. Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. Int Clin Psychopharmacol. 2004 Sep;19(5):271-80}}&lt;br /&gt;
&amp;lt;noinclude&amp;gt;[[Category:References]]&amp;lt;/noinclude&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Project:Background&amp;diff=6349</id>
		<title>Project:Background</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Project:Background&amp;diff=6349"/>
		<updated>2011-07-11T12:23:43Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More information and/or sources of switching antidepressants and antipsychotics&lt;br /&gt;
&lt;br /&gt;
* '''Mission statement:''' to improve independently psychopharmacotherapy and medication safety for all patients.&lt;br /&gt;
[[image:WB paraplu.JPG|thumb|right|Walter Broekema]]&lt;br /&gt;
* '''Walter Broekema (1953) is the founder and editor-in-chief of this WIKI'''. &lt;br /&gt;
He is hospital pharmacist and head of the clinical pharmacy department at [http://www.ggzcentraal.nl GGz Centraal] in Amersfoort, The Netherlands. &lt;br /&gt;
He also has pharmaceutical responsibility for a number of other Mental Health Institutions. He graduated as a pharmacist in 1979 and gained his specialisation `hospital pharmacist' in 1991. He has worked at university and community pharmacy. He is active in several organisations inside and outside the hospital, nationally and internationally. He is president of the Special Interest Group Psychiatry of the Dutch Association of Hospital Pharmacists (NVZA/KNMP). &lt;br /&gt;
He initiated the ATC-drug-distribution robot, started an early audiovisual quality manual and is active in several E-projects like this one. One of his favourites is multidisciplinary cooperation and education. He actively participates in (inter)national conferences. &lt;br /&gt;
Conflict of interests: no pharmaceutical companies nor financial interest is involved. Declared 2011.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Acknowledgements'''&lt;br /&gt;
* ''' Ralph de Backer, MSc, PharmD''': benzodiazepines&lt;br /&gt;
* ''' Jaap Kerkvliet, MSc, PharmD''': flagged revisions&lt;br /&gt;
* ''' Klaas Kooistra, MSc, PharmD''': moodstabilizers&lt;br /&gt;
* ''' Ashni Lo-Kim-Lin, BSc, coming up MSc, PharmD''': general&lt;br /&gt;
* ''' Lenneke Minjon, BSc, coming up MSc, PharmD''': plain stopping antidepressants (in progress)&lt;br /&gt;
* ''' Alexandra Mulder, MSc, PharmD''': antidepressants&lt;br /&gt;
* ''' Verena Mulder, MSc, PharmD''': antipsychotics&lt;br /&gt;
* ''' Mariska de Roo, PharmD''': general &amp;amp; authorization&lt;br /&gt;
* ''' Arent Storm, MSc''': benzo convertor&lt;br /&gt;
* ''' Arend Veeninga, psychiatrist, PhD''': tester user interface&lt;br /&gt;
&lt;br /&gt;
'''Improvements'''&lt;br /&gt;
* We are gradually improving the tables by adding more references, graphics etc. This will take time.&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
* [[interne link|feedback]]&lt;br /&gt;
* [http://www.extern.nl/link externe link]&lt;br /&gt;
* [[wp:wiki|wikilink]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;big&amp;gt;Further&amp;lt;/big&amp;gt; reading and/or sources of '''switching antidepressants'''&lt;br /&gt;
--&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6348</id>
		<title>Stop-duloxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6348"/>
		<updated>2011-07-11T12:15:46Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| stop = &lt;br /&gt;
* plain stop: {{refBazire}}&lt;br /&gt;
:*'''Day 1:''' reduce dosage of duloxetine to 60 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of duloxetine to 30 mg/day. &lt;br /&gt;
:* '''Day 29 or later:''' stop administration of duloxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6347</id>
		<title>Stop-duloxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6347"/>
		<updated>2011-07-11T12:15:11Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| stop = &lt;br /&gt;
* plain stop {{refBazire}}&lt;br /&gt;
:*'''Day 1:''' reduce dosage of duloxetine to 60 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of duloxetine to 30 mg/day. &lt;br /&gt;
:* '''Day 29 or later:''' stop administration of duloxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefBazire&amp;diff=6346</id>
		<title>Template:RefBazire</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Template:RefBazire&amp;diff=6346"/>
		<updated>2011-07-11T12:13:01Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: Created page with '&amp;lt;ref&amp;gt;[Bazire S, Psychotropic Drug Directory 2010. Aberdeen: HealthComm UK Ltd; 2010.]&amp;lt;/ref&amp;gt;'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;ref&amp;gt;[Bazire S, Psychotropic Drug Directory 2010. Aberdeen: HealthComm UK Ltd; 2010.]&amp;lt;/ref&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6345</id>
		<title>Stop-duloxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6345"/>
		<updated>2011-07-11T12:09:50Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| stop = &lt;br /&gt;
* {{refBazire}}&lt;br /&gt;
:*'''Day 1:''' reduce dosage of duloxetine to 60 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of duloxetine to 30 mg/day. &lt;br /&gt;
:* '''Day 29 or later:''' stop administration of duloxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6343</id>
		<title>Stop-duloxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Stop-duloxetine&amp;diff=6343"/>
		<updated>2011-07-11T11:56:28Z</updated>

		<summary type="html">&lt;p&gt;Lenneke: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch&lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| stop = &lt;br /&gt;
* All dosages &amp;lt;ref&amp;gt;[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.225.](dutch)&amp;lt;/ref&amp;gt;:&lt;br /&gt;
:*'''Day 1:''' reduce dosage of duloxetine to 60 mg/day. &lt;br /&gt;
:*'''Day 8:''' reduce dosage of duloxetine to 30 mg/day. &lt;br /&gt;
:* '''Day 29 or later:''' stop administration of duloxetine.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Lenneke</name></author>
		
	</entry>
</feed>